Beyond tumor mutation burden: tumor neoantigen burden as a superior prognostic biomarker in resected gastric cancer
In summary, this study indicated that the prognosis of TNB-High patients was significantly better than their counterparts, which might be associated with impaired energy metabolism.
Authors
- Tingting Lu (ORCID: https://orcid.org/0009-0007-3435-1852)
- Zhida Chen (ORCID: https://orcid.org/0000-0002-7936-2703)
- Xiaoxin Pan
- H. H. Zhang
- Yi Wang (ORCID: https://orcid.org/0000-0003-0797-5209)
- Jian Wang (ORCID: https://orcid.org/0000-0002-4127-322X)
- Yuyu Liu (ORCID: https://orcid.org/0000-0002-4814-8616)
- Hongqing Xi
- Fenglin Zhang
- Gan Zhang
- Jingyi Cao
- Ji Wan
- Peng Liu
- Yiming Shen
Institutions
- Chinese PLA General Hospital (CN)
- Beike Biotechnology (China) (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-05
- DOI
- https://doi.org/10.3389/fimmu.2025.1722895
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00